Humanum BRF Gene V600e Mutationem
Product Name
HWTs-TM007-Humanum Braf Gene V600E Mutationem Deprehensio Kit (Fluorescence PCR)
Certificatorium
Ce / tfda
Epidemiology
Plus quam XXX genera Braf mutationum inventa, de quibus de XC% sunt sita in Exon XV, ubi V600e mutationem consideretur esse maxime commune mutationem, quod est, in Exon XV est mutari Adenine (a), unde in replacement de Valine (v) ad positus DC per glutamic acidum (E) in dapibus productum. BRF mutationes sunt communiter in malignantium tumores ut melanoma, coloreectal cancer, thyroidei cancer et pulmone cancer. Intelligendo mutationem de BRF gene est facti opus ad screen EGFR-TKIS et BRF Gene mutationem, targeted medicamentis in orci targeted medicamento Lorem pro aegris qui potest esse beneficium.
Channel
Fam | V600e mutationem, internum imperium |
Technical parametri
Repono | ≤, XVIII ℃ |
PLUTEUM-vitae | IX menses |
Specimen Type | paraffin-embedded pathologicum TEXTUS exempla |
CV | <5.0% |
Ct | ≤38 |
LOD | Utere kits ad deprehendere correspondentes LOD qualitas imperium. a) sub 3ng / μl bestiis-genus background, I% mutationem rate potest deprehendi in reactionem quiddam stabiliter; b) sub I% mutationem rate, mutationem de I × X3Copies / ml in fera-type background de I × X5Copies / ML potest esse stabiliter deprehendi in reactionem quiddam; c) in IC reactionem quiddam potest deprehendere in lowest deprehendatur terminus qualitas imperium Sw3 de turba internum imperium. |
Applicabiles instrumenta: | Applicari Biosystems (VII) D Real-vicis PCR SystemsApplicari Biosystems (VII) CCC Real-vicis PCR Systems, quantstudio® V Real-vicis PCR systems LightcyCler®®®® Real-vicis PCR ratio BIOD CFX96 Real-vicis PCR ratio |
ADMODO
Commendatur extraction Reagents: Qiagen est Qiaamp DNA FFPE TEXTUS Kit ((LVI) CDIV), Paraffin-embedded TEXTUS DNA celeri extraction extraction Ornamentum (DP330) fabricari per Tiangen Biotech (Beijing) Co., Ltd